LENSAR, Inc. Common Stock (LNSR) is a publicly traded Healthcare sector company. As of May 21, 2026, LNSR trades at $5.88 with a market cap of $68.15M and a P/E ratio of 5.93. LNSR moved +0.52% today. Year to date, LNSR is -47.64%; over the trailing twelve months it is -57.94%. Its 52-week range spans $4.20 to $17.31. Analyst consensus is buy with an average price target of $8.50. Rallies surfaces LNSR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LENSAR’s ALLY Gains 23.4% Market Share as Margins Slide to 46%: LENSAR’s ALLY Robotic Laser Cataract System captured 23.4% US market share in 2025, up from 14% in 2024, while full-year gross margin fell to 46% from 48% due to inflation and tariffs. Operating expenses are expected to rise 10% to $38-39 million in 2026 as distributor re-engagement delays revenue growth.
| Metric | Value |
|---|---|
| Price | $5.88 |
| Market Cap | $68.15M |
| P/E Ratio | 5.93 |
| EPS | $0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.31 |
| 52-Week Low | $4.20 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $57.70M |
| Net Income | $29.40M |
| Gross Margin | 45.71% |
2 analysts cover LNSR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.50.